|
Using PPMI to study long term PD progression
|
|
5
|
103
|
March 22, 2024
|
|
So you've done a GWAS - what's next? Part 2 - Gene-based & enrichment analyses
|
|
0
|
123
|
February 21, 2024
|
|
GitHub Platform
|
|
4
|
79
|
February 26, 2024
|
|
GP2 bioinformatics course
|
|
2
|
65
|
February 18, 2024
|
|
So you've done a GWAS - what's next? Part 1 - SNP annotation & function
|
|
3
|
226
|
February 13, 2024
|
|
Collecting data: Improving and standarizing methods
|
|
2
|
56
|
February 12, 2024
|
|
AMP PD Terra Resources
|
|
0
|
79
|
October 11, 2023
|
|
Plasma Biomarkers in Fox Insight
|
|
12
|
144
|
November 14, 2023
|
|
Bioinfomatics workflow management tool
|
|
2
|
76
|
October 24, 2023
|
|
Explanation of Terra platform
|
|
1
|
80
|
October 3, 2023
|
|
Fox Insight question
|
|
2
|
60
|
October 3, 2023
|
|
Systematic review methodology tips
|
|
1
|
62
|
September 8, 2023
|
|
Analyzing Repetitive Head Impact/TBI data in Fox Insight
|
|
5
|
82
|
September 5, 2023
|
|
Provenance: how and why to track it
|
|
3
|
63
|
August 21, 2023
|
|
Is α-synuclein seed amplification analysis data already present in the PPMI data?
|
|
6
|
141
|
August 18, 2023
|
|
What makes useful metadata so that you can reuse and analyze data sets?
|
|
1
|
39
|
August 17, 2023
|
|
New Resource: AMP PD Target Explorer
|
|
4
|
88
|
August 16, 2023
|
|
Which are the correct identifiers for patients in the PPMI cohort?
|
|
6
|
182
|
August 8, 2023
|
|
Discovering patients who got a PD diagnosis in PPMI and Fox Insight cohorts
|
|
4
|
93
|
June 22, 2023
|
|
Best analyses to combine PD data with other neurodegenerative disease data
|
|
2
|
51
|
June 15, 2023
|